Stockscreener 앱 받기
5.39
11.59%
0.56
시간 외 거래:
5.27
-0.12
-2.23%
전일 마감가:
$4.83
열려 있는:
$5.1
하루 거래량:
32,159
Relative Volume:
1.72
시가총액:
$34.99M
수익:
$598.00K
순이익/손실:
$-21.81M
주가수익비율:
-1.3083
EPS:
-4.12
순현금흐름:
$-16.66M
1주 성능:
+1.70%
1개월 성능:
+20.58%
6개월 성능:
+24.48%
1년 성능:
-2.36%
1일 변동 폭
$5.00
$5.4065
1주일 범위
$4.61
$5.4065
52주 변동 폭
$3.33
$7.13
Pluri Inc Stock (PLUR) Company Profile
명칭
Pluri Inc
전화
972-74-710-7171
주소
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
PLUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
5.39 | 34.99M | 598.00K | -21.81M | -16.66M | -4.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pluri Inc 주식(PLUR)의 최신 뉴스
Insiders Sold Pluri At US$5.87, Meanwhile Stock Sits Near US$4.30 - simplywall.st
Plurilock Security (CVE:PLUR) Stock Price Up 7.8% – Here’s What Happened - Defense World
Pluri (NASDAQ:PLUR) Now Covered by Alliance Global Partners - Defense World
Alliance Global Partners Initiates Coverage of Pluri (TASE:PLUR) with Buy Recommendation - Nasdaq
Alliance Global Partners Initiates Coverage of Pluri (PLUR) with Buy Recommendation - Nasdaq
Alliance Global Partners Initiates Coverage on Pluri (PLUR) with a "Buy" Rating | PLUR Stock News - GuruFocus
BCLI: Receives Regulatory Clearance to Initiate Phase 3b ALS Trial… - MSN
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials - The Malaysian Reserve
Pluri Inc. reschedules 2025 annual meeting By Investing.com - Investing.com South Africa
Pluri Inc. reschedules 2025 annual meeting - Investing.com
BrainStorm partners with Minaris for ALS therapy trial By Investing.com - Investing.com Canada
BrainStorm partners with Minaris for ALS therapy trial - Investing.com
BrainStorm Accelerates NurOwn ALS Treatment Development Through Major Manufacturing Deal with Minaris - Stock Titan
Pluri (NASDAQ:PLUR) vs. CARGO Therapeutics (NASDAQ:CRGX) Head-To-Head Review - Defense World
Cellular Therapeutics Market Poised for Explosive Growth, Driven by Innovative Companies - citybuzz -
4 Stocks To Watch In The $47 Billion Cellular Therapeutics Market - FinancialContent
Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion - TradingView
Pluri Achieves 400% Revenue Surge as Biotech Pioneer Enters $130B Cacao and Coffee Markets - Stock Titan
Pluri (NASDAQ:PLUR) & Qiagen (NYSE:QGEN) Head to Head Contrast - Defense World
Pluri: Fiscal Q3 Earnings Snapshot - New Haven Register
Pluri Regains Nasdaq Compliance Before Deadline - TipRanks
Renaissance Technologies LLC Boosts Stock Position in Pluri Inc. (NASDAQ:PLUR) - Defense World
Q&A with Alejandro Weinstein, Pluri Board of Directors - citybiz
Pluri Inc. sets date for 2025 shareholder meeting By Investing.com - Investing.com Canada
Pluri Inc. sets date for 2025 shareholder meeting - Investing.com
Pluri acquires 71% stake in Kokomodo - Food Business News
Pluri Inc. acquires majority stake in Kokomodo Ltd. By Investing.com - Investing.com Canada
Pluri Acquires 71% Of Kokomodo To Advance Climate-Resilient Cultivated Cacao Production - Nasdaq
Pluri Inc. acquires majority stake in Kokomodo Ltd. - Investing.com
$13.5B Cacao Market Disruption: Pluri Acquires Cellular Agriculture Pioneer Kokomodo for Climate-Resilient Future - Stock Titan
Pluri Inc. enters agreement, issues pre-funded warrants - Investing.com Australia
Pluri Inc. enters agreement, issues pre-funded warrants By Investing.com - Investing.com Canada
Pluristem stock soars to 52-week high, hits $6.63 By Investing.com - Investing.com South Africa
Pluristem stock soars to 52-week high, hits $6.63 - Investing.com Australia
DarioHealth Announces CFO Transition - The Malaysian Reserve
DarioHealth Announces CFO Transition - Benzinga
DarioHealth Taps Israeli CFO Excellence Award Winner to Lead Next Growth Phase - Stock Titan
Pluri Inc. subsidiary loses $4.2 million NIAID contract By Investing.com - Investing.com Canada
Pluri Inc. subsidiary loses $4.2 million NIAID contract - Investing.com Australia
Pluri IncPluri Biotech Receives Termination Notice From Niaid Of ContractSEC Filing - marketscreener.com
Analyzing X4 Pharmaceuticals (NASDAQ:XFOR) & Pluri (NASDAQ:PLUR) - Defense World
Pluri Inc. (NASDAQ:PLUR) Short Interest Update - Defense World
Pluri’s immune cell expansion technologies gain patents - Yahoo Finance
Pluri Announces Expansion of Intellectual Property Portfolio wit - GuruFocus
Pluri Inc (PLUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):